PARAGANGLIOMA
Clinical trials for PARAGANGLIOMA explained in plain language.
Never miss a new study
Get alerted when new PARAGANGLIOMA trials appear
Sign up with your email to follow new studies for PARAGANGLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental drug tested for rare, stubborn cancers in kids and adults
Disease control TerminatedThis study tested whether a drug called SGI-110 could shrink or slow the growth of certain rare cancers that don't respond well to standard treatments. It was for people aged 12 and older with specific types of gastrointestinal, adrenal, or kidney cancers that had progressed desp…
Matched conditions: PARAGANGLIOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Experimental vaccine fights rare adrenal cancers
Disease control TerminatedThis study tested a new cancer vaccine called EO2401 combined with an immunotherapy drug for people with advanced adrenal cancers that had spread. The goal was to see if this combination was safe and could help control these rare, aggressive tumors. The trial enrolled 70 adults w…
Matched conditions: PARAGANGLIOMA
Phase: PHASE1, PHASE2 • Sponsor: Enterome • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC